Answers are grounded in this paper and cite their sources.
Background and Aims: GPR15L (encoded by GPR15LG/C10orf99) is a colon-restricted peptide that combines direct antimicrobial activity with chemoattractant signalling through GPR15, whereas dipeptidyl peptidase-4 (DPP-4) and its substrate glucagon-like peptide-2 (GLP-2) govern epithelial repair. Whether these three mediators behave as a coordinated epithelial axis across the activity spectrum of ulcerative colitis (UC), has not been established in a single patient cohort spanning mild, moderate-to-severe and quiescent disease. Methods: One hundred and twenty participants were enrolled: 30 with moderate-to-severe active UC, 30 with mildly active UC, 30 with UC in clinical and endoscopic remission, and 30 healthy controls. Serum GPR15L, serum DPP-4 concentration, plasma DPP-4 enzymatic activity and total immunoreactive GLP-2 were quantified by enzyme-linked immunosorbent assay. Faecal calprotectin was measured by ELISA. Disease activity was graded by the total Mayo score and the Mayo endoscopic subscore (MES). Group comparisons, Spearman correlation, receiver-operating-characteristic (ROC) analysis and multivariable logistic regression were performed. Results: Serum GPR15L decreased stepwise with increasing disease activity (median 184, 268, 395 and 448 pg/mL in moderate-to-severe UC, mild UC, remission and controls, respectively; P < 0.001). Serum DPP-4 and plasma DPP-4 activity showed the same downward gradient, whereas total immunoreactive GLP-2 rose progressively (38.6 ± 11.4 versus 16.9 ± 5.1 pmol/L; P < 0.001) and correlated inversely with DPP-4 (ρ = −0.55). GPR15L correlated inversely with the total Mayo score (ρ = −0.68), the Mayo endoscopic subscore (ρ = −0.64), faecal calprotectin (ρ = −0.71) and C-reactive protein (ρ = −0.46; all P < 0.001). For discriminating active disease from remission, GPR15L achieved an area under the curve (AUC) of 0.88 (cut-off ≤ 312 pg/mL; sensitivity 86.7%, specificity 83.3%); a three-marker composite reached an AUC of 0.94, against 0.93 for faecal calprotectin. All three mediators remained independent predictors of disease activity after adjustment for age, sex and body mass index. Conclusions: Active UC is characterised by concurrent depletion of the colonic antimicrobial peptide GPR15L and of DPP-4, accompanied by an accumulation of circulating GLP-2 that is consistent with reduced enzymatic inactivation together with an unmet reparative demand. GPR15L tracks the activity gradient more closely than either of the other two mediators and merits evaluation as a serum marker of colonic epithelial integrity alongside faecal calprotectin.
No takes yet. Share an insight, caveat, or question.
Hiba Ahmed Mahmood (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: